Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC4481276/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC4481276/. The analysis below is for the second page.

Title[redir]:
Inhibitory Receptors Beyond T Cell Exhaustion - PMC
Description:
Inhibitory receptors (iRs) are frequently associated with “T cell exhaustion”. However, the expression of iRs is also dependent on T cell differentiation and activation. Therapeutic blockade of various iRs, also referred to as “checkpoint blockade”, ...

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 6,694,437 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't tell how the site generates income.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Ncbi.nlm.nih.gov could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cells, cell, pubmed, google, scholar, doi, expression, irs, pmc, article, free, immune, cancer, differentiation, activation, exhaustion, patients, function, ctla, infection, receptors, tumor, melanoma, immunol, clinical, inhibitory, levels, blockade, functional, chronic, receptor, responses, ligands, tim, effector, human, btla, subsets, high, functions, pdl, studies, costimulatory, healthy, biomarkers, anticd, cytokine, exhausted, express, subset,

Topics {✒️}

tumor-infiltrating ny-eso-1-specific cd8+ tyr–xaa–xaa–met motif mismatch-repair-proficient colon cancers single-agent anti-programmed death-1 antibody-dependent cell-mediated cytotoxicity ipilimumab-dependent cell-mediated cytotoxicity anti-programmed-death-receptor-1 treatment increased recurrence-free survival tyrosine-based inhibition motif tumor-infiltrating pd1-positive lymphocytes itim motif-carrying immunoreceptor arh1/tam/aram/yxxl tumor-infiltrated lymph nodes pmc beta search pd1/pd-l1 specific antibodies fc gamma riib reduced treatment-free survival cell receptor-mediated signaling c-type lectin superfamily antibody-dependent cellular cytotoxicity pd-1 receptor-deficient mice protein-tyrosine phosphatase shp-1 pd-1-expressing tumor-infiltrating curr hiv/aids rep induced immune-related colitis randomised dose-comparison cohort cytomegalovirus-specific human cd8 sh2 domain-mediated activation broad inter-individual variability long-lasting stem cell fcr-dependent cell activation dual tim-3/pd-1 expression tumor-infiltrating immune cells including human pd-l1 anti-pd-l1 antibodies anti-tumor immune responses pd-1/pd-l1 blockade tumor antigen-specific cd8+ human tumor-specific cd8 tumor antigen-specific cd8 human tumor-specific cd8+ long-term survival data ipilimumab-refractory advanced melanoma intratumoral pd-l1 expression poor naïve repertoire transcriptional profiles reveal anti-cd3 antibody coated yxxl sequences separated cell-extrinsic mechanisms [reviewed patients receiving anti-pd1

Questions {❓}

  • In fact, there is as yet limited knowledge concerning iR function and the signaling of the various iRs: what are the precise molecular pathways, the signaling cascades and events downstream of the interactions of iRs with their respective iR ligands?
  • Inhibitory receptors abound?
  • The evolution of checkpoint blockade as a cancer therapy: what’s here, what’s next?

External Links {🔗}(300)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

4.2s.